DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,219,776 | -21.9% | 21,039 | -24.5% | 0.26% | +15.7% |
| Q2 2023 | $6,685,200 | +28.7% | 27,855 | +38.5% | 0.22% | +2.8% |
| Q3 2022 | $5,196,000 | -78.6% | 20,116 | -75.7% | 0.22% | -75.9% |
| Q1 2022 | $24,250,000 | +2905.0% | 82,673 | +3270.3% | 0.90% | +2474.3% |
| Q4 2021 | $807,000 | -82.5% | 2,453 | -83.8% | 0.04% | -84.5% |
| Q3 2021 | $4,624,000 | -55.7% | 15,188 | -61.0% | 0.23% | -53.7% |
| Q2 2021 | $10,438,000 | +459.7% | 38,894 | +363.2% | 0.49% | +221.1% |
| Q4 2020 | $1,865,000 | -77.3% | 8,396 | -78.0% | 0.15% | -78.9% |
| Q3 2020 | $8,233,000 | +39.5% | 38,234 | +14.5% | 0.72% | +6.6% |
| Q2 2020 | $5,903,000 | +89.1% | 33,383 | +48.0% | 0.68% | -2.4% |
| Q1 2020 | $3,122,000 | -80.2% | 22,559 | -78.1% | 0.69% | -58.0% |
| Q4 2019 | $15,796,000 | – | 102,920 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |